金宇生物技术股份有限公司发布回购股份事项前十大股东持股情况公告
公告要点
- 公司于2026年6月5日召开第十二届董事会第六次会议，通过以集中竞价方式回购股份的议案。
- 公告详细披露了回购股份决议前一个交易日（2026年6月5日）前十大股东及前十大无限售条件股东的持股情况。
- 回购专用证券账户持股19,014,900股，占公司总股本的1.71%，显示回购进度。
- 公司所有股份均为无限售条件流通股，前十大无限售条件股东与前十大股东名单一致。
详细内容
金宇生物技术股份有限公司（证券代码：600201，证券简称：生物股份）于2026年6月5日召开董事会会议，审议通过了《关于以集中竞价交易方式回购股份方案的议案》。公司随后在上海证券交易所网站发布了相关预案，公告编号为临2026-025。
根据《上市公司股份回购规则》和《上海证券交易所上市公司自律监管指引第7号——回购股份》等规定，公司公告了回购股份决议的前一个交易日（2026年6月5日）登记在册的前十大股东和前十大无限售条件股东的名称、持股数量及持股比例。
前十大股东持股情况
| 序号 | 股东名称 | 持股数量（股） | 占公司股份总数的比例（%） |
|---|---|---|---|
| 1 | 内蒙古金宇生物控股有限公司 | 125,510,800 | 11.29 |
| 2 | 伟星资产管理（上海）有限公司－宁波梅山保税港区星棋道和股权投资合伙企业（有限合伙） | 40,689,655 | 3.66 |
| 3 | 上海淳韬投资管理有限公司－淳韵价值一号证券投资私募基金 | 40,358,474 | 3.63 |
| 4 | 浙商银行股份有限公司－国泰中证畜牧养殖交易型开放式指数证券投资基金 | 25,618,170 | 2.30 |
| 5 | 香港中央结算有限公司 | 24,811,619 | 2.23 |
| 6 | 张翀宇 | 23,003,826 | 2.07 |
| 7 | 韩丽营 | 13,360,000 | 1.20 |
| 8 | 余必英 | 9,651,200 | 0.87 |
| 9 | 鲁泽珞 | 9,600,000 | 0.86 |
| 10 | 韩丽丹 | 9,600,000 | 0.86 |
公告特别指出，公司回购专用证券账户持股19,014,900股，已回购股份占公司总股本的1.71%。该回购进度对投资者具有高度关注价值，因股份回购通常被视为利好，可增强公司股价表现并显示公司对未来发展的信心。
所有股份均为无限售条件流通股，前十大无限售条件股东与前十大股东名单一致，显示公司股权结构公开透明。
投资者关注要点
- 股份回购进度明确，回购股份已占总股本1.71%，有助于提升每股收益和公司价值。
- 前十大股东结构稳定，尤其是控股股东内蒙古金宇生物控股有限公司持有公司11.29%的股份，显示公司控制权集中。
- 回购计划和进度的披露可能对公司股价产生积极影响，建议投资者关注后续回购进展及相关公告。
- 公司股权全部为无限售条件流通股，有利于市场交易流动性。
Disclaimer
本文仅为信息披露，不构成投资建议。投资者应结合自身风险偏好，充分了解公司经营、回购计划及相关政策后，审慎决策。
Jinyu Biotechnology Co., Ltd. Announces Share Buyback and Top Ten Shareholders Detailed Disclosure
Key Highlights
- The company held its 12th Board of Directors’ sixth meeting on June 5, 2026, approving a share buyback by centralized bidding.
- Announcement provides detailed disclosure on the top ten shareholders and top ten unrestricted shareholders as of June 5, 2026.
- The dedicated buyback securities account holds 19,014,900 shares, representing 1.71% of total share capital, indicating buyback progress.
- All shares are unrestricted and tradable; the top ten unrestricted shareholders are identical to the top ten shareholders.
Details
Jinyu Biotechnology Co., Ltd. (Stock code: 600201, Stock abbreviation: Jinyu Bio) convened its board meeting on June 5, 2026, passing the proposal for a share buyback via centralized bidding. The buyback proposal was subsequently published on the Shanghai Stock Exchange website (Announcement No. 临2026-025).
In accordance with the “Share Buyback Rules for Listed Companies” and “Shanghai Stock Exchange Listed Companies Self-Regulatory Guidelines No. 7—Share Buyback”, the company disclosed information on the top ten shareholders and top ten unrestricted shareholders (as of June 5, 2026): names, holdings, and shareholding ratios.
Top Ten Shareholders
| No. | Shareholder Name | Shares Held | % of Total Shares |
|---|---|---|---|
| 1 | Inner Mongolia Jinyu Biological Holdings Co., Ltd. | 125,510,800 | 11.29 |
| 2 | Weixing Asset Management (Shanghai) Co., Ltd. – Ningbo Meishan Bonded Port Area Xingqidaohe Equity Investment Partnership (Limited Partnership) | 40,689,655 | 3.66 |
| 3 | Shanghai Chuntao Investment Management Co., Ltd. – Chunyun Value No. 1 Securities Investment Private Fund | 40,358,474 | 3.63 |
| 4 | Zhejiang Commercial Bank Co., Ltd. – GT CSI Livestock Breeding ETF | 25,618,170 | 2.30 |
| 5 | Hong Kong Securities Clearing Company | 24,811,619 | 2.23 |
| 6 | Zhang Chongyu | 23,003,826 | 2.07 |
| 7 | Han Liying | 13,360,000 | 1.20 |
| 8 | Yu Biying | 9,651,200 | 0.87 |
| 9 | Lu Zeluo | 9,600,000 | 0.86 |
| 10 | Han Lidan | 9,600,000 | 0.86 |
It is highlighted that the company’s dedicated buyback securities account has acquired 19,014,900 shares, now representing 1.71% of total share capital. This buyback progress is important for investors, as share buybacks are often viewed as a positive signal, potentially boosting share price and demonstrating management’s confidence in future prospects.
All shares are unrestricted and tradable, enhancing liquidity, and shareholder transparency.
Key Investor Takeaways
- Clear buyback progress: 1.71% of total shares already repurchased, likely to improve EPS and overall company value.
- Stable top ten shareholder structure, with the controlling shareholder holding 11.29% of shares, indicating concentrated control.
- Disclosure of buyback plan and progress may positively impact share price; investors should monitor further buyback developments and related announcements.
- All shares are unrestricted, supporting market liquidity and trading.
Disclaimer
This article is for information disclosure purposes only and does not constitute investment advice. Investors should fully understand the company’s operations, buyback plan, and relevant policies, and make decisions prudently according to their own risk preferences.
